ATE231879T1 - Verfahren zur herstellung von clarithromycinkristallen der form ii - Google Patents

Verfahren zur herstellung von clarithromycinkristallen der form ii

Info

Publication number
ATE231879T1
ATE231879T1 AT99941861T AT99941861T ATE231879T1 AT E231879 T1 ATE231879 T1 AT E231879T1 AT 99941861 T AT99941861 T AT 99941861T AT 99941861 T AT99941861 T AT 99941861T AT E231879 T1 ATE231879 T1 AT E231879T1
Authority
AT
Austria
Prior art keywords
crystals
clarithromycin
water
producing clarithromycin
producing
Prior art date
Application number
AT99941861T
Other languages
English (en)
Inventor
Tae Suk Lee
Bundang-Gu Sunae-Dong
Ju Cheol Lee
Kyoung Ik Lee
Gwan Sun Lee
Wan Joo Kim
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Application granted granted Critical
Publication of ATE231879T1 publication Critical patent/ATE231879T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT99941861T 1998-09-09 1999-09-08 Verfahren zur herstellung von clarithromycinkristallen der form ii ATE231879T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-1998-0037181A KR100377159B1 (ko) 1998-09-09 1998-09-09 잔류 용매가 없는 클라리스로마이신의 결정형 2의 제조 방법
PCT/KR1999/000530 WO2000014099A1 (en) 1998-09-09 1999-09-08 Method of preparing form ii crystals of clarithromycin

Publications (1)

Publication Number Publication Date
ATE231879T1 true ATE231879T1 (de) 2003-02-15

Family

ID=19550077

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99941861T ATE231879T1 (de) 1998-09-09 1999-09-08 Verfahren zur herstellung von clarithromycinkristallen der form ii

Country Status (8)

Country Link
US (1) US6506886B1 (de)
EP (1) EP1112280B1 (de)
JP (1) JP3779155B2 (de)
KR (1) KR100377159B1 (de)
AT (1) ATE231879T1 (de)
DE (1) DE69905176T2 (de)
ES (1) ES2192072T3 (de)
WO (1) WO2000014099A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
KR100377159B1 (ko) * 1998-09-09 2003-08-19 한미약품공업 주식회사 잔류 용매가 없는 클라리스로마이신의 결정형 2의 제조 방법
WO2001044262A1 (en) 1999-12-16 2001-06-21 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin polymorphs and novel polymorph iv
AU2261901A (en) * 2000-01-11 2001-07-24 Teva Pharma Processes for preparing clarithromycin polymorphs
US6544555B2 (en) * 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
KR20030047873A (ko) * 2000-02-29 2003-06-18 테바 파마슈티컬 인더스트리즈 리미티드 클라리트로마이신 및 클라리트로마이신 중간체의 제조방법, 실질적으로는 옥심이 제거된 클라리트로마이신 및이를 포함하는 약학적 조성물
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
KR100408848B1 (ko) * 2001-03-12 2003-12-06 주식회사 씨트리 클래리스로마이신의 정제방법
SI1390377T1 (sl) * 2001-05-22 2006-06-30 Pfizer Prod Inc Nova kristalna oblika azitromicina
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
ES2258142T3 (es) * 2001-05-22 2006-08-16 Pfizer Products Inc. Nueva forma cristalina.
AU2004258953B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004258949B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2006528185A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
CA2535177A1 (en) * 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
US8062672B2 (en) * 2003-08-12 2011-11-22 Shionogi Inc. Antibiotic product, use and formulation thereof
AU2004270170B2 (en) * 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2538064C (en) * 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004308419B2 (en) * 2003-12-24 2011-06-02 Victory Pharma, Inc. Enhanced absorption of modified release dosage forms
CA2572292A1 (en) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
JP2009500356A (ja) * 2005-07-07 2009-01-08 エラン ファーマ インターナショナル リミテッド ナノ粒子クラリスロマイシン製剤
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
CN103087130B (zh) * 2013-02-06 2015-12-23 浙江国邦药业有限公司 一种克拉霉素晶型转换方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187140A (en) * 1989-10-18 1993-02-16 Union Carbide Chemicals & Plastics Technology Corporation Alkylene oxide catalysts containing high silver content
DE69730138T2 (de) * 1996-07-29 2005-03-03 Abbott Laboratories, Abbott Park Herstellung von kristallinen form ii von clarithromycin
US5844105A (en) * 1996-07-29 1998-12-01 Abbott Laboratories Preparation of crystal form II of clarithromycin
US5858986A (en) * 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
US5945405A (en) * 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
KR100377159B1 (ko) * 1998-09-09 2003-08-19 한미약품공업 주식회사 잔류 용매가 없는 클라리스로마이신의 결정형 2의 제조 방법

Also Published As

Publication number Publication date
JP2002524465A (ja) 2002-08-06
EP1112280A1 (de) 2001-07-04
JP3779155B2 (ja) 2006-05-24
US6506886B1 (en) 2003-01-14
KR20000019206A (ko) 2000-04-06
DE69905176T2 (de) 2003-10-09
EP1112280B1 (de) 2003-01-29
DE69905176D1 (de) 2003-03-06
KR100377159B1 (ko) 2003-08-19
WO2000014099A1 (en) 2000-03-16
ES2192072T3 (es) 2003-09-16

Similar Documents

Publication Publication Date Title
DE69905176D1 (de) Verfahren zur herstellung von clarithromycinkristallen der form ii
DE69413727D1 (de) Verfahren zur Herstellung von Kohlenstoffdioxid-Absorptionsmittel durch Verwendung von Betonschlamm
DE69305238D1 (de) Verfahren zur Herstellung von grossen Monokristallen
DE69009353D1 (de) Verfahren zur Behandlung von organischen Abwässern durch Methangärung.
DE69319270D1 (de) Verfahren zur Behandlung von organischen Schlämmen
DE69029268D1 (de) Verfahren und anlage zur herstellung eines organischen düngemittels
DE69737127D1 (de) Zusammensetzung und Verfahren zur Behandlung von Pflanzen mit exogenen Chemikalien
DE69426970D1 (de) Verfahren zur Behandlung einer Ölquelle
DE3882011D1 (de) Verfahren und vorrichtung zur herstellung von biopolymer-einkristall.
DE69431642D1 (de) Verfahren zur Herstellung von stabilisiertem Polycarbonat
DE69837041D1 (de) Verfahren und mikroorganism zur herstellung von purin-nukleosiden durch fermentation
DE69003944D1 (de) Verfahren zur gesteuerten anaeroben zersetzung von abfall.
DE69522517D1 (de) Verfahren zur Herstellung von verstärkten Steinplatten
ATE232211T1 (de) Verfahren zur herstellung von form ii kristallen des clarithromycins
DE69802581D1 (de) Verfahren zur Züchtung von Einkristallen
DE60040886D1 (de) Vorrichtung und Verfahren zur Reinigung von leicht blockierende Substanzen enthaltenden organischen Stoffen
DE59504792D1 (de) Verfahren zur Herstellung von Serienventilen
DE69412559D1 (de) Verfahren zur Vergasung von organischen Materien
DE69520139D1 (de) Verfahren zur herstellung von flüssigkristallcomposit
DE69927486D1 (de) Verfahren zur herstellung von flüssigen polyfunktionellen zusätzen
DE59705140D1 (de) Verfahren und Vorrichtung zur Herstellung von Einkristallen
DE60013451D1 (de) Verfahren und vorrichtung zur herstellung von hochqualitativen einkristallen
DE59505084D1 (de) Kontinuierliches Verfahren zur Herstellung von organischen Isocyanaten
DE69315012D1 (de) Verfahren zur Herstellung von aromatischen organischen Karbonaten
DE69700509D1 (de) Verfahren zur Herstellung von Allylsilanen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties